Gallagher to continue tuck-in mergers after Willis Re deal collapses
July 30 2021 by InsuranceAsia News
-
Edme Insurance Brokers names Sanjay Radhakrishnan as CEO
- November 13
Mumbai-based Radhakrishnan has been a founding member of Edme since its establishment following the sale of Aditya Birla Insurance Brokers to private equity firm Samara Capital Group.
-
RJC Insurance Brokers launches in New South Wales
- November 11
The broker will be led by managing directors Russell and Julie Chegwyn and will place and manage covers for businesses in industries ranging from rail construction & maintenance to civil construction.
-
Marsh’s Dennis Dalati joins Gallagher as APAC head of claims
- November 8
Dalati has relocated from Singapore to Australia and oversees claims management across Australia and Asia for the broker.
-
Steadfast expands into London market with US$30m Lloyd’s broker HW Wood buy
- November 7
The acquisition, which is expected to be completed on December 2, gives the Australian group full ownership of the target, including its operations in France and Greece.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
